Medical Condition News

RSS

Larger sized intravenous anesthetic diazepam incubated in isolation with Aβ peptide does not promote aggregation

Alzheimer's disease (AD) is a neurodegenerative disorder affecting millions of people worldwide and has become a major global concern. Uncontrolled oligomerization (aggregation) of Aβ peptide is the hallmark of AD and it is believed to be causally related to AD pathomechanism.

22 Apr 2010

KSERA research project focuses on COPD patients

To enable elderly people to live at home as long as possible, a group of European researchers, coordinated from Eindhoven University of Technology, will link robots and 'smart homes'. The robot, a 'sensible family friend', will ensure that home is a nice place to stay. And that patients do the right things.

22 Apr 2010

Removable methyl groups on specific genes of autistic individuals that led to gene silencing identified

A new study by researchers at The George Washington University School of Medicine and Health Sciences' Department of Biochemistry and Molecular Biology raises hope that autism may be more easily diagnosed and that its effects may be more reversible than previously thought.

22 Apr 2010

Martial arts training may help osteoporosis sufferers fall more safely: BMC Research Notes

Martial arts could be the key to helping osteoporosis sufferers fall more safely. A study published in the open access journal BMC Research Notes has found that martial arts training can likely be carried out safely.

22 Apr 2010

Titan Pharmaceuticals expects approximately $1.6M as royalty on first-quarter sales of Fanapt

Titan Pharmaceuticals, Inc. today confirmed that the company expects to receive a payment of approximately $1.6 million by May 15, 2010 as the royalty on the first quarter 2010 sales of Fanapt™ (iloperidone), a drug for the treatment of schizophrenia launched in the US by Novartis Pharma AG in January 2010.

22 Apr 2010

Understanding genetic causes of mental retardation

This remarkable publication focuses on the importance of genetics in mental retardation, investigating the extent to which molecular diagnostic capability and the understanding of genetic causes have improved over recent years. As a result, clinical evaluation and diagnostic laboratory practice are now undergoing an unprecedented period of change.

22 Apr 2010

ISHLT announces new guidelines for heart transplant recipients

The International Society for Heart and Lung Transplantation (ISHLT) today announces new guidelines to standardize care for heart transplant patients worldwide. The guidelines demonstrate a united effort to decrease complications, improve outcomes and increase patient survival rates among heart transplant recipients. The guidelines will be presented during today's symposium The ISHLT Guidelines for Heart Transplant Recipients: Towards an International Consensus at the ISHLT 30th Annual Meeting and Scientific Sessions at the Hilton Chicago.

22 Apr 2010

New studies on cancer prevention presented at 101st AACR Annual Meeting 2010

Interest in cancer prevention is increasing as scientists continue to learn new information and confirm what was already suspected.

22 Apr 2010

Alnylam Pharmaceuticals presents new data on ALN-TTR01 RNAi therapeutic at amyloidosis symposium

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, presented new pre-clinical data from its ALN-TTR program at the XII International Symposium on Amyloidosis in Rome on April 18 - 21, 2010. ALN-TTR01 is a systemically delivered RNAi therapeutic being developed for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), including familial amyloidotic polyneuropathy (FAP) and familial amyloidotic cardiomyopathy (FAC).

22 Apr 2010

COX-2 expression not an adequate independent prognostic factor: Research

Cyclooxygenase-2 represents a key modulatory molecule in inflammation and carcinogenesis. COX-2 is known to have multiple tumorigenic effects. Increased expression of COX-2 has been observed in a variety of tumors including pancreatic cancer.

22 Apr 2010

Immunomedics reports on ribonuclease-based immunotoxin development at AACR meeting

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported results from two studies on the development of ribonuclease-based immunotoxins at the American Association for Cancer Research conference.

22 Apr 2010

Age delays time taken for recovery of sense of taste following nerve injury

Age dramatically delays the time if takes to recover the sense of taste following a significant nerve injury, Medical College of Georgia researchers said.

22 Apr 2010

AVEO Pharmaceuticals presents data on potential utility of Notch1-specific monoclonal antibody at 101st AACR

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced preclinical data which demonstrate that its Notch1-specific monoclonal antibody is a highly potent inhibitor of Notch1 function in both in vitro and in vivo models. These data were presented today at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010 in Washington, D.C.

22 Apr 2010

Research findings may help personalize use of statins, scientists say

Researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center have discovered why statins -- popular drugs that lower cholesterol and appear to protect against colorectal cancer development -- work for some people, but not for all.

22 Apr 2010

Secrets, solutions, strategies and shortcuts to win against personal autism challenges

Howard Rodgers remembers the day his son was born. His mind was teeming with positive thoughts about how this small child would change the world. Then, reality came back - for a very long visit. His son was diagnosed with one of the worst cases of autism doctors and specialists had ever seen.

22 Apr 2010

University of Nevada professor awarded NIH RO1 grant for study of control of motility in internal anal sphincter

Kathleen Keef, Ph.D., professor of physiology and cell biology at the University of Nevada School of Medicine, has been awarded a four-year, $1.2 million grant from the National Institute of Health to study the control of motility in the internal anal sphincter.

22 Apr 2010

PharmaMar presents new trials with Yondelis, Zalypsis and Irvalec anti-tumor drugs at 101st AACR meeting

PharmaMar, a biopharmaceutical company owned by Grupo Zeltia (ZEL.MC), presented six new trials with marine-based anti-tumor drugs Yondelis(R), Zalypsis(R) and Irvalec(R) at the American Association for Cancer Research's (AACR) 101st Annual Meeting, held in Washington, D.C. from April 17-21.

22 Apr 2010

Green tea catechins may protect against glaucoma and other common eye diseases: Scientists

Scientists have confirmed that the healthful substances found in green tea - renowned for their powerful antioxidant and disease-fighting properties - do penetrate into tissues of the eye. Their new report, the first documenting how the lens, retina, and other eye tissues absorb these substances, raises the possibility that green tea may protect against glaucoma and other common eye diseases.

22 Apr 2010

Non-invasive coronary CTA cost-effective alternative to invasive cardiac catheterization for CAD evaluation

According to a study conducted at Thomas Jefferson University (TJU), non-invasive coronary computed tomography angiography (CTA) is a cost-effective alternative to invasive cardiac catheterization in the care of patients who have positive stress test results but a less than 50 percent chance of actually having significant coronary artery disease (CAD). The study will be published in the May issue of the American Journal of Roentgenology.

22 Apr 2010

Penn State researchers to test education program on patients with high blood pressure

When it comes to chronic diseases, knowledge is power, according to Penn State researchers who will test an education program on patients with high blood pressure to help them manage their disease.

22 Apr 2010

Medical Condition News

Larger sized intravenous anesthetic diazepam incubated in isolation with Aβ peptide does not promote aggregation

KSERA research project focuses on COPD patients

Removable methyl groups on specific genes of autistic individuals that led to gene silencing identified

Martial arts training may help osteoporosis sufferers fall more safely: BMC Research Notes

Titan Pharmaceuticals expects approximately $1.6M as royalty on first-quarter sales of Fanapt

Understanding genetic causes of mental retardation

ISHLT announces new guidelines for heart transplant recipients

New studies on cancer prevention presented at 101st AACR Annual Meeting 2010

Alnylam Pharmaceuticals presents new data on ALN-TTR01 RNAi therapeutic at amyloidosis symposium

COX-2 expression not an adequate independent prognostic factor: Research

Immunomedics reports on ribonuclease-based immunotoxin development at AACR meeting

Age delays time taken for recovery of sense of taste following nerve injury

AVEO Pharmaceuticals presents data on potential utility of Notch1-specific monoclonal antibody at 101st AACR

Research findings may help personalize use of statins, scientists say

Secrets, solutions, strategies and shortcuts to win against personal autism challenges

University of Nevada professor awarded NIH RO1 grant for study of control of motility in internal anal sphincter

PharmaMar presents new trials with Yondelis, Zalypsis and Irvalec anti-tumor drugs at 101st AACR meeting

Green tea catechins may protect against glaucoma and other common eye diseases: Scientists

Non-invasive coronary CTA cost-effective alternative to invasive cardiac catheterization for CAD evaluation

Penn State researchers to test education program on patients with high blood pressure

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News